|
|
Press Releases
First-In-Class Drug BBI608 Tested in Patients with Advanced Cancer
Next Generation RNAi Technology Discovered
by AiRNA Pharmaceuticals and Boston
Biomedical Published in Nature Biotechnology
ArQule spins out Boston Biomedical with $5M research deal
ArQule discovery arm carries on as Boston Biomedical
Business Conferences
Science Conferences
|
|
